Product Information
HEMORRHOIDAL SUPPOSITORIES is a generic product labeled by Rugby Laboratories, priced at $0.2881 per EA under NDC 00536118612. Its NADAC has been published 409 times since Dec 5, 2018.
Strength
2211; 6.5 mg/1; mg/1
Manufacturer
Rugby LaboratoriesNDC
00536118612
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M015On Market Since
8/22/2018
Pharmacological Classes
Price Statistics
The NADAC for HEMORRHOIDAL SUPPOSITORIES has been published 409 times since Dec 5, 2018, and over the history we have for it it has risen 56.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2881 per EA |
|---|---|
| All-time high | $0.2970 (Sep 16, 2026) |
| All-time low | $0.1695 (Apr 19, 2023) |
| 52-week high | $0.2970 |
| 52-week low | $0.2393 |
| Median price | $0.2025 |
| Average price | $0.2085 |
| Largest weekly change | +23.8% (May 17, 2023) |
| Weeks tracked | 409 |
| Tracking since | Dec 5, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cocoa butter, phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HEMORRHOIDAL SUPPOSITORIES?
The current National Average Drug Acquisition Cost (NADAC) for HEMORRHOIDAL SUPPOSITORIES, manufactured by Rugby Laboratories, is $0.2881 per EA (NDC 00536118612), effective Sep 30, 2026.
How has the price of HEMORRHOIDAL SUPPOSITORIES changed over time?
Over the history we have for it, the NADAC for HEMORRHOIDAL SUPPOSITORIES has risen 56.6%. It has been tracked across 409 weekly CMS publications since Dec 5, 2018.
What are the highest and lowest recorded NADAC prices for HEMORRHOIDAL SUPPOSITORIES?
Since Dec 5, 2018, the NADAC for HEMORRHOIDAL SUPPOSITORIES has ranged from a low of $0.1695 (Apr 19, 2023) to a high of $0.2970 (Sep 16, 2026), with a median of $0.2025 per EA.
Are there cheaper alternatives to HEMORRHOIDAL SUPPOSITORIES?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HEMORRHOIDAL SUPPOSITORIES, is $0.1840 per EA — about 36% below HEMORRHOIDAL SUPPOSITORIES.
Who manufactures HEMORRHOIDAL SUPPOSITORIES?
HEMORRHOIDAL SUPPOSITORIES (NDC 00536118612) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.